The use of plants and their products for medical treatment is very common 13 procedure in Brazil, especially for treatment of diabetes. In fact, several plants can 14 demonstrate hypoglycemic effects in vitro assays. However, the use for human 15 treatment requires the knowledge of their toxicological properties. The aim of this study 16 was to evaluate the effect of protein extracts of Chrysobalanus icaco collected from 17 natural habitats and of Eugenia astringens acquired from the market of Rio de Janeiro 18 on the viability and migration of fibroblasts. E. astringens has a similar morphology as 19 C. icaco and it is sold as Chrysobalanus in a popular market in Rio de Janeiro. Being a 20 different plant, E. astringens expresses different proteins, and its protein extract has 21 proved to possess higher toxic properties than C. icaco does. Cytotoxicity assays 22 indicated that, as the protein extract concentration increases, fibroblast viability 23 decreases. Only the E. astringens extract displayed cytotoxicity at all concentrations, in 24 addition to reduced fibroblast migration. The results obtained in this study demonstrates 25 that it's necessary integrative policies for rational use of medicinal plants and their 26 commercialization, since the current use of medicinal plants may be inadequate and it is 27 of great importance for Public Health. 28
Introduction 32 33
Several plants are widely used for medical purposes by the population, but this 34 use is most often made from a lay indication, without knowing the risks of toxic effects. 35
Besides, there is no guarantee of the provenance and proper storage of these supposedly 36 "medicinal plants". It is clear that there is a lack of incentive and scientifically-based 37 information to integrative and complementary practices and actions to promote the safe 38 and rational use of medicinal plants, including information on how the species should 39 be prepared and used by the population (Bochner et al., 2012) . 40
The leaf extract (tea) of the plant Chrysobalanus icaco L., a species of restinga 41 popularly known as abajerú, is used in folk medicine because it exerts biological 42 activities, such as the decrease of blood sugar levels, being indicated for the treatment of 43 diabetes, besides be diuretic and antioxidant (Venancio et al., 2018) . Another plant 44 (Eugenia astringens, Cambess.) which is morphologically similar to C. icaco, also is 45 known by the same popular name of abajerú and is commercialized as C icaco (Bochner 46 et al., 2012; Silva and Peixoto, 2009 ). These two species may not possess the same 47 therapeutic and toxicological properties, which are of concern to Public Health. The 48 attribution of hypoglycemic activity to E. astringens may indicate a misconception 49 since other species of Myrtaceae have hypoglycemic potential (Silva and Peixoto, 50 2009 ). So, in order to clarify the toxicological aspects of the extract obtained from these 51 2 plants, a cytotoxic assay was performed. 52
For cytotoxicity studies in animal cells several techniques, using distinct cell 53 types as a target, are available. Cytotoxicity means the determination of any toxic effecs 54 at the cellular level, such as changes in membrane permeability, cell death or enzymatic 55 inhibition resulted from exposure to a toxicant, in this case, the studied plants or plant 56 products (Stockert et al., 2012) . 57
Cell viability can be evaluated by several methods, among which the one which 58 involves the conversion of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium 59 bromide (MTT) to formazan by mitochondrial reactivation in active-living cells (Zandi 60 et al., 2016) . The MTT assay is a standard colorimetric assay that estimates the 61 cytotoxic potential of the samples, in addition to measuring the cellular proliferation of 62 drug agents. Cell viability is expressed as a percentage of live cells from the tested 63 material, comparing with the percentage of cells of the cytotoxicity positive control 64 (Stockert et al., 2018) . 65
Another test to evaluate the toxicity of the plant extract is the Scratch Wound 66
Healing Assay, which allows measuring the migration of cells that is a phenomenon 67 present in the healing process. It is a method in which a crack imitates a wound in a 68 monolayer of confluent cells so that the cells at the edge gradually move towards the 69 crack (Manoj et al., 2009 ). Wound healing is the process of repairing and regenerating 70 the dermis and epidermis that accompanies the lesions (Liang et al., 2007; Pitz et al., 71 2016) . The evaluation of the healing activity of plant extracts is scarce at the cellular 72 level. Fibroblast cultures have been proposed as a method for the investigation of 73 wound healing activity, since these cells are the main source of extracellular connective 74 tissue matrix and the migration of fibroblasts is considered vital for rapid and effective 75 skin repair damaged (Manoj et al., 2009) . 76
The lack of data about the toxicity of the protein extract of these 2 plants Praia Grande -RJ) on fibroblasts viability was evaluated through the MTT assay 121 (Mosmann, 1983) . 122
The cells were seeded in a 96 well plates and placed in CO 2 incubator overnight. 123
The cells were then treated with different sample solutions (1, 5, 10 and 20 μ g/mL) in 124 four replicates. The control group was treated only with the medium (DMEM). After 125 treatment, a solution of MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium 126 bromide) (5 mg/mL in phosphate buffered saline -1X PBS pH 7.4) was added to each 127 well and incubated for 4 hours. Subsequently, the supernatant was discarded and 150 μ l 128 of dimethyl sulfoxide were added for solubilization of the formazan crystals. The and E. astringens can cause confusion (Fig. 2) , the E. astringens leaf has a fold around 184 it facing the abaxial part ( Fig. 2c ) not found in C. icaco. Fibroblasts (3T3 cell line) were submitted to the cell viability assay, exposed to 205 different concentrations of protein extract and to the cell migration assay, exposed to a 206 determined concentration of this extract. 207 208
Cell viability assay 209 210
To evaluate the effects of extracts of E. astringens (MAD), C. icaco (RMA), C. 211 icaco (AL) and C. icaco (PG) on fibroblast viability, the MTT assay was performed. 212
The results for the cell viability assay are shown in Fig. 3 As shown in Figure 4 , treatment with C. icaco (RMA), C. icaco (AL) and C. 240 icaco (PG) was not able to alter the migration rate of fibroblasts. On the other hand, it 241 can be noted that the treatment with E. astringens led to a significant reduction in the 242 migration of these cells by 26.04% (p <0.05), comparing to the control. 243
The migration of fibroblast is illustrated in Fig. 5 There is a misunderstanding regarding the sale of abajerú in Mercadão de 263 Madureira, where Eugenia astringens, of the same popular name, is sold in place of 264
Chrysobalanus icaco. This is of great concern to Public Health, because C. icaco is 265 popularly used as medicinal plant for treating diabetes, due to its hypoglycemic 266 potential. Meanwhile the population consumes tea from the leaves of E. astringens, 267 coming from these markets instead of C. icaco. Medicinal plants are widely used due to 268 their easy accessibility, but they usually not have their efficacy and safety well 269 established (Bochner et al., 2012) . This fact can become a risk to those who use them 270 since they can cause more deleterious effects than bring health benefits. It is of prime 271 importance to inspect qualified individuals, traders, distributors and producers for 272 regularization of the sale of medicinal plants. Eucalyptus, are used by the population for this purpose and have antioxidant, antifungal 282 and antibacterial properties (Queiroz et al., 2015) . Also, the natural environments to 283 which C. icaco occurs are restinga-type vegetation sites, which are usually areas of 284 environmental protection, which makes it difficult to collect specimens of this species. 285
Therefore, this could also be a hypothesis regarding the introduction of E. astringens, 286
replacing C. icaco in popular marketing. This species is not hypoglycemic like C. icaco, 287 which can lead to intoxication in those people who buy erroneously, thinking that they 288 are acquiring the correct abajerú plant. 289
Since medicinal plants may also have unknown toxicological properties, the 290 evaluation of toxicity, through in vitro tests, is required. Cytotoxicity of the extracts of 291 medicinal plants, including those that are hypoglycemic, can affect cellular processes 292 like healing that is crucial for diabetic patients. Hyperglycemia alters leukocyte 293 function, increasing the risk of bleeding and impairing inflammatory and healing 294 processes (Negri, 2005; Aquino et al., 2019) . This difficulty in healing occurs due to 295 cardiovascular complications, which cause blockage or decrease of blood circulation, 296 and due to excess glucose, which can impair the functioning of the immune system. 297
That is, diseased vessels decrease blood flow, especially to the legs and feet, harming 298 the healing process and high glycemic levels incapacitate the body's defense cells (Hu et 299 al., 2002) . 
